The most straightforward approach to vaccine development would be based on inactivated or attenuated strains of SARSCoV-2, but the production of sufficient material generally takes longer than is the case for subunit vaccines, high-level containment would be necessary to grow the virus before attenuation/inactivation, and the candidates would carry a risk of reacquired virulence . For subunit …
Continue reading “The most common formats for these tests are the ELISA and lateral flow assay”